Biblio

Found 5 results
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Traboulsee, A  [Clear All Filters]
2011
Riddell CA, Zhao Y, Li DK, Petkau AJ, Riddehough A, Cutter GR, Traboulsee A. Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis. Neurology [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=22094474
Tam RC, Traboulsee A, Riddehough A, Sheikhzadeh F, Li DK. The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis. Mult Scler [Internet]. 2011;17:949-957. Available from: http://www.hubmed.org/display.cgi?uids=21502309
Bar-Or A, Rieckmann P, Traboulsee A, Yong VW. Targeting progressive neuroaxonal injury: lessons from multiple sclerosis. CNS Drugs [Internet]. 2011;25:783-799. Available from: http://www.hubmed.org/display.cgi?uids=21870889
2010
Ebers GC, Traboulsee A, Li D, Langdon D, Reder AT, Goodin DS, Bogumil T, Beckmann K, Wolf C, Konieczny A, et al. Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial. J Neurol Neurosurg Psychiatry [Internet]. 2010. Available from: http://www.hubmed.org/display.cgi?uids=20562430
2009
Ebers GC, Reder AT, Traboulsee A, Li D, Langdon D, Goodin DS, Wolf C, Beckmann K, Konieczny A, Investigators of the 16-Year Long-Term Follow-Up Study, et al. Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study. Clin Ther [Internet]. 2009;31:1724-1736. Available from: http://www.hubmed.org/display.cgi?uids=19808131